Hepatitis C Treatment Centers
Bennet Cecil, M.D.
Hepatitis C is the number one fatal infection in the USA according to the Center for Disease Control and Prevention (CDC). If not cured, HCV kills one-third of infected persons. Kentucky has huge problem with HCV because of our heroin epidemic.
We opened Hepatitis C Treatment Centers in 1998, and we have cured more than 2,500 patients. HCTC is the largest HCV treatment center in the USA. We are located at 1009A Dupont Square North in Louisville KY. Call (502) 894-9950 for an appointment.
Our second location is at 124 Dowell Road in Russell Springs, KY. Call (270) 866-2440 for an appointment.
If you do not live close to Louisville or Russell Springs, we can treat you via Telehealth. Instead of coming to our office, you go to your regular primary care provider (PCP). We will order your tests and medications. We will consult with you and your PCP face to face by computer. We can treat any HCV patient in Kentucky who has a primary care provider who is willing to collaborate with us. Ask your PCP to refer you to us for treatment.
The development of oral antivirals has pushed the cure rates above 95%, even in patients with cirrhosis. Mavyret, Epclusa, Harvoni and Vosevi are excellent drugs without the side effects of interferon.
Bennet Cecil, MD
Board certified in Internal Medicine and Gastroenterology
Hepatitis C Treatment Centers is an important force in the effort to eradicate HCV in the Commonwealth of Kentucky.
Hepatitis C Treatment Centers is an important force in the effort to eradicate HCV in the Commonwealth of Kentucky. We have cured more than 2,600 patients with HCV in the past five years. Because more than 1/3 of uncured patients die from liver cancer or liver failure we have prevented nearly 900 deaths. By extending […]
Kentucky has 54 high-risk counties for spread of hepatitis C; only six have needle exchange programs
By Melissa Patrick Kentucky Health News Why, if 54 of Kentucky’s 120 counties are among the nation’s most vulnerable to outbreaks of HIV and hepatitis C among intravenous drug users, do only a few of them allow users to exchange used syringes for clean one to avoid spreading the diseases? That question was asked, implicitly, […]